Jiadi Gan

553 total citations
19 papers, 292 citations indexed

About

Jiadi Gan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jiadi Gan has authored 19 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Jiadi Gan's work include Lung Cancer Treatments and Mutations (14 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (4 papers). Jiadi Gan is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (4 papers). Jiadi Gan collaborates with scholars based in China and Hong Kong. Jiadi Gan's co-authors include Yihua Huang, Wenfeng Fang, K. Wang, Wenjing Wang, Xiaodong Zhou, Li Zhang, Shaodong Hong, Yingjin Wang, Zhonghan Zhang and Minghui Wang and has published in prestigious journals such as Cancer, Cancer Research and International Journal of Cancer.

In The Last Decade

Jiadi Gan

17 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiadi Gan China 11 183 175 93 61 43 19 292
Priscilla Cascetta Italy 10 135 0.7× 234 1.3× 142 1.5× 84 1.4× 39 0.9× 15 368
Martina Pagliuca Italy 9 108 0.6× 118 0.7× 73 0.8× 46 0.8× 38 0.9× 30 255
L. Paz-Ares Spain 9 215 1.2× 291 1.7× 97 1.0× 40 0.7× 27 0.6× 51 374
Beili Gao China 10 106 0.6× 135 0.8× 122 1.3× 42 0.7× 22 0.5× 24 278
Vishal Boolell Australia 6 191 1.0× 190 1.1× 71 0.8× 49 0.8× 28 0.7× 11 352
Masayuki Yasugi Japan 9 241 1.3× 240 1.4× 132 1.4× 48 0.8× 17 0.4× 22 358
Anna Manzo Italy 10 170 0.9× 248 1.4× 164 1.8× 73 1.2× 14 0.3× 25 398
Daniela Iacono Italy 9 266 1.5× 228 1.3× 141 1.5× 64 1.0× 27 0.6× 19 372
Manfred Kindler Germany 12 131 0.7× 179 1.0× 148 1.6× 100 1.6× 43 1.0× 28 381
Maria Maddalena Laterza Italy 10 143 0.8× 192 1.1× 59 0.6× 79 1.3× 81 1.9× 35 342

Countries citing papers authored by Jiadi Gan

Since Specialization
Citations

This map shows the geographic impact of Jiadi Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiadi Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiadi Gan more than expected).

Fields of papers citing papers by Jiadi Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiadi Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiadi Gan. The network helps show where Jiadi Gan may publish in the future.

Co-authorship network of co-authors of Jiadi Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiadi Gan. A scholar is included among the top collaborators of Jiadi Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiadi Gan. Jiadi Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Shi, Yuan, Yuan Fang, Yanxia Hu, et al.. (2025). CRTC1 enhances PD-L1-mediated tumor immunosuppression in non-small cell lung cancer via the Notch1/Akt signaling pathway. Frontiers in Immunology. 16. 1658679–1658679.
2.
Pang, Lanlan, Jiadi Gan, Yihua Huang, et al.. (2023). Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy. BMC Cancer. 23(1). 72–72. 10 indexed citations
3.
Pang, Lanlan, Yihua Huang, Jiadi Gan, et al.. (2023). Exploration of immunotherapy in advanced pulmonary lymphoepithelioma‐like carcinoma. International Journal of Cancer. 152(11). 2338–2350. 10 indexed citations
4.
Liu, Dongcheng, Hongguang Liu, Jiadi Gan, et al.. (2022). LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC. Frontiers in Pharmacology. 13. 918317–918317. 6 indexed citations
5.
Huang, Yihua, C. Xu, Wenxian Wang, et al.. (2022). Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patients. Lung Cancer. 172. 117–123. 1 indexed citations
6.
7.
8.
9.
Gan, Jiadi, et al.. (2021). HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy. OncoTargets and Therapy. Volume 14. 5297–5307. 12 indexed citations
10.
Gan, Jiadi, Wenfeng Fang, & Li Zhang. (2021). Therapy of lung cancer in China: introducing the special collection. Therapeutic Advances in Medical Oncology. 13. 4277450231–4277450231. 1 indexed citations
11.
Gan, Jiadi, Yihua Huang, Wenfeng Fang, & Li Zhang. (2021). Research progress in immune checkpoint inhibitors for lung cancer in China. Therapeutic Advances in Medical Oncology. 13. 4277441858–4277441858. 20 indexed citations
12.
Chen, Qian, Yihua Huang, Han Han‐Zhang, et al.. (2020). <p>An <em>EGFR</em>-Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report</p>. OncoTargets and Therapy. Volume 13. 1845–1849. 12 indexed citations
13.
Fang, Wenfeng, Yihua Huang, Weiguang Gu, et al.. (2020). PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy. Translational Lung Cancer Research. 9(4). 1258–1267. 74 indexed citations
14.
Fang, Wenfeng, Yihua Huang, Shaodong Hong, et al.. (2019). EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer. BMC Cancer. 19(1). 595–595. 90 indexed citations
15.
16.
17.
Gan, Jiadi, Yingjin Wang, & Xiaodong Zhou. (2018). Whether a Short or Long Alimentary Limb Influences Weight Loss in Gastric Bypass: a Systematic Review and Meta-Analysis. Obesity Surgery. 28(11). 3701–3710. 16 indexed citations
18.
Gan, Jiadi & Xiaodong Zhou. (2018). Comparison of urine neutrophil gelatinase-associated lipocalin and interleukin-18 in prediction of acute kidney injury in adults. Medicine. 97(39). e12570–e12570. 10 indexed citations
19.
Gan, Jiadi, Yingjin Wang, & Xiaodong Zhou. (2018). Stem cell transplantation for the treatment of patients with type�1 diabetes mellitus: A meta‑analysis. Experimental and Therapeutic Medicine. 16(6). 4479–4492. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priscilla Cascetta Breakdown of academic impact, for papers by Martina Pagliuca Breakdown of academic impact, for papers by L. Paz-Ares Breakdown of academic impact, for papers by Beili Gao Breakdown of academic impact, for papers by Vishal Boolell Breakdown of academic impact, for papers by Masayuki Yasugi Breakdown of academic impact, for papers by Anna Manzo Breakdown of academic impact, for papers by Daniela Iacono Breakdown of academic impact, for papers by Manfred Kindler Breakdown of academic impact, for papers by Maria Maddalena Laterza
Rankless by CCL
2026